Deodorant compositions

US12246081B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12246081-B2
Application numberUS-201816769518-A
CountryUS
Kind codeB2
Filing dateDec 12, 2018
Priority dateDec 20, 2017
Publication dateMar 11, 2025
Grant dateMar 11, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a deodorant composition comprising an oxazolidine- or, a thiazolidine-carboxylic acid compound, a cosmetic carrier and optionally a fragrance. The invention also relates to a manufacturing process for the deodorant composition, a method of treating malodour and a method of screening deodorant actives as well as inhibiting a Staphylococcus hominis C-S ≥-lyase.

First claim

Opening claim text (preview).

The invention claimed is: 1. A human deodorant composition comprising: (1) an oxazolidine-carboxylic acid compound; and (2) a cosmetic carrier; wherein the oxazolidine-carboxylic acid compound is: (i) a compound of formula (I); (ii) an ester of a compound of formula (I); (iii) a salt of a compound of formula (I); or (iv) a compound that releases a compound of formula (I) in use; wherein X is O; wherein R 1 , R 2 and R 3 are same or different group; wherein R 1 is hydrogen, C3-C20 linear alkyl, C3-C20 branched alkyl, C3-C20 cyclic alkyl, C3-C20 alkenyl, C3-C20 aryl residue, or mixtures thereof; wherein R 2 and R 3 are each independently C3-C20 linear alkyl, C3-C20 branched alkyl, C3-C20 cyclic alkyl, C3-C20 alkenyl, C3-C20 aryl residue, mixtures thereof, or linked to form a cyclic structure; wherein the deodorant composition is a topical deodorant composition; and wherein the cosmetic carrier comprise a water-insoluble organic material. 2. The deodorant composition according to claim 1 , wherein R 1 is H. 3. The deodorant composition according to claim 1 , wherein the oxazolidine-carboxylic acid compound is selected from the group consisting of(S) (−)-3-(benzyloxycarbonyl)-4-oxazolidinecarboxylic acid, (R)-(+)-3-(benzyloxycarbonyl)-4-oxazolidinecarboxylic acid, (4S)-3-(tert-butoxycarbonyl)-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid, 1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid wherein N is protected by carboxybenzyl (Cbz), 1,8-dioxa-4-azaspiro[4.5]decane-3-carboxylic acid, and 1,8-dioxa-4-azaspiro[4.5]decane-3-carboxylic acid wherein N is protected by Cbz. 4. The deodorant composition according to claim 1 , wherein the oxazolidine-carboxylic acid compound is present in an amount of 0.001% to 10% by weight based on a total weight of the deodorant composition. 5. The deodorant composition according to claim 1 , further comprising a delivery aid for the oxazolidine-carboxylic acid compound, wherein the delivery aid is an amino alcohol comprising at least 3 carbons. 6. The deodorant composition according to claim 1 , further comprising a fragrance. 7. A cosmetic method of treating malodour comprising topical application of a deodorant composition to a surface of human body, wherein the deodorant composition comprises: (1) an oxazolidine-carboxylic acid compound; and (2) a cosmetic carrier; wherein the oxazolidine-carboxylic acid compound is: (i) a compound of formula (I); (ii) an ester of a compound of formula (I); (iii) a salt of a compound of formula (I); or (iv) a compound that releases a compound of formula (I) in use; wherein X is O; wherein R 1 , R 2 and R 3 are same or different group; wherein R 1 is hydrogen, C3-C20 linear alkyl, C3-C20 branched alkyl, C3-C20 cyclic alkyl, alkenyl, aryl residue, or mixtures thereof; wherein R 2 and R 3 are each independently C3-C20 linear alkyl, C3-C20 branched alkyl, C3-C20 cyclic alkyl, alkenyl, aryl residue, mixtures thereof, or linked to form a cyclic structure. 8. The cosmetic method according to claim 7 , wherein the oxazolidine-carboxylic acid compound inhibits C-S β layse. 9. The cosmetic method according to claim 7 , further comprising: dissolving or homogenously dispersing the oxazolidine-carboxylic acid compound in the cosmetic carrier.

Assignees

Inventors

Classifications

  • Anti-perspirants or body deodorants (deodorisation of air A61L9/00) · CPC title

  • Enzyme modulators, e.g. Enzyme agonists · CPC title

  • Mixtures · CPC title

  • Enzymes · CPC title

  • A61K8/49Primary

    containing heterocyclic compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12246081B2 cover?
The present invention relates to a deodorant composition comprising an oxazolidine- or, a thiazolidine-carboxylic acid compound, a cosmetic carrier and optionally a fragrance. The invention also relates to a manufacturing process for the deodorant composition, a method of treating malodour and a method of screening deodorant actives as well as inhibiting a Staphylococcus hominis C-S ≥-lyase.
Who is the assignee on this patent?
Conopco Inc
What technology area does this patent fall under?
Primary CPC classification A61K8/49. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).